Related references
Note: Only part of the references are listed.A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
Agnieszka Dansonka-Mieszkowska et al.
BMC MEDICAL GENETICS (2010)
The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
A-Yong Cao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
PALB2 sequence variants in young South African breast cancer patients
Michelle Sluiter et al.
FAMILIAL CANCER (2009)
PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
Shirley M. -H. Sy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
The Fanconi anaemia/BRCA pathway and cancer susceptibility.: Searching for new therapeutic targets
M. Jose Garcia et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Penetrance analysis of the PALB2 c.1592delT founder mutation
Hannele Erkko et al.
CLINICAL CANCER RESEARCH (2008)
Analysis of PALB2/FANCN-associated breast cancer families
Marc Tischkowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A recurrent mutation in PALB2 in Finnish cancer families
Hannele Erkko et al.
NATURE (2007)
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Bing Xia et al.
NATURE GENETICS (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
William D. Foulkes et al.
BREAST CANCER RESEARCH (2007)
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B. Evers et al.
ONCOGENE (2006)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations
MD Westfall et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
DI Kutler et al.
BLOOD (2003)
Biallelic inactivation of BRCA2 in Fanconi anemia
NG Howlett et al.
SCIENCE (2002)
The emerging genetic and molecular basis of Fanconi anaemia
H Joenje et al.
NATURE REVIEWS GENETICS (2001)